BioSight vs Upstream Bio
BioSight vs Upstream Bio, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioSight is on 37/100 and Upstream Bio on 61/100.
Where each one leads
BioSight
- agent readiness: 46/100 against 39/100
Upstream Bio
- our overall score: 61/100 against 37/100
- domain rating: 32/100 against 12/100
- headcount: 75 against 3
- headcount growth: +43.4% against -30.1%
- funding raised: $400M against $1.5M
- LinkedIn following: 11,799 against 681
At a glance
| Measure | BioSight | Upstream Bio |
|---|---|---|
| What it is | Clinical-stage biotech developing novel therapeutics for hematological malignancies and disorders. | Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases. |
| Category | Life Sciences, Biotech, MedTech, HealthTech | Life Sciences, Therapeutics, Biotech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 1999 | 2021 |
| Headquarters | Tel Aviv, Israel | Waltham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BioSight | Upstream Bio |
|---|---|---|
| Employees | 3 | 75 |
| Headcount growthLast 12 months | -30.1% | +43.4% |
| Total funding | $1.5M | $400M |
| Latest round | Not published | Series B |
| LinkedIn followers | 681 | 11,799 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioSight | Upstream Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 37/100 | 61/100 |
| Traction | 37/100 | 59/100 |
| Team | Not published | 70/100 |
| Search visibility | 32/100 | 37/100 |
| Quality | 45/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (46/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 12/100 | 32/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioSight | Upstream Bio |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Wix | WordPress |
| Frameworks | Not detected | Jquery, Bootstrap |
| Analytics | Not detected | Google Tag Manager |
BioSight vs Upstream Bio: common questions
Which is better, BioSight or Upstream Bio?
On our 0-100 score Upstream Bio rates higher (61/100 against 37/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do BioSight and Upstream Bio compare on the numbers?
BioSight leads on agent readiness (46/100 against 39/100). Upstream Bio leads on our overall score (61/100 against 37/100), domain rating (32/100 against 12/100), headcount (75 against 3), headcount growth (+43.4% against -30.1%), funding raised ($400M against $1.5M), LinkedIn following (11,799 against 681).
Read the full BioSight review and pricing or the Upstream Bio review and pricing. You can also browse other BioSight alternatives we track.